Clinical Trial Update: Interferon α 2b Pharmacovigilance Study [Phase 4]

View source ↗

Summary

A Phase 4 pharmacovigilance trial evaluating Interferon alfa-2b in chronic hepatitis C patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | Conditions: Hepatitis C, Chronic | Phase 4 | Status: COMPLETED